CASE REPORT
CD99-positive undifferentiated round cell sarcoma diagnosed
on fine needle aspiration cytology, later found to harbour a
CIC-DUX4 translocation: a recently described entity
B. Kajt ar*, T. Torn oczky*, E. K alm an*, J. Kuzsner
†
, P. C. W. Hogendoorn
‡
and
K. Szuhai
§
*Department of Pathology and
†
Department of Orthopaedics, University of P ecs, Hungary
‡
Department of Pathology and
§
Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands
Accepted for publication 4 May 2013
Introduction
Poorly differentiated, small round cell sarcomas
often represent a serious differential diagnostic prob-
lem. CD99 expression was initially considered to be
specific for Ewing sarcoma (ES); however, it may
also be seen in many histologically similar neo-
plasms. The differential diagnosis of these tumours
includes mesenchymal chondrosarcoma, poorly dif-
ferentiated synovial sarcoma and lymphoblastic lym-
phoma. However, rarely, CD99 expression may
appear in other neoplasms of a similar morphology
such as the blastemal component of Wilms’ tumour,
small cell osteosarcoma, rhabdomyosarcoma, small
cell carcinomas, etc., further expanding the list of
differentials.
1
Here we describe a case of CD99-posi-
tive, EWSR1-translocation negative undifferentiated
small round cell sarcoma with plasmacytoid mor-
phology, which was initially diagnosed on fine nee-
dle aspiration (FNA) cytology and subsequently
found on molecular analysis of a resection specimen
to harbour the CIC-DUX4 translocation.
Correct recognition of these entities is facilitated
by cytogenetic or molecular genetic studies. Some of
the above neoplasms are characterized by specific
cytogenetic abnormalities; primary examples are
synovial sarcoma characterized by SYT-translocations
and ES harbouring EWSR1-translocations in the
majority of cases.
1
Recently, a BCOR–CCNB3 gene
fusion described in undifferentiated sarcoma of the
bone has been added to the list of such cytogenetic
abnormalities.
2
A proportion of small blue round cell tumours
(SBRCT) lack a characteristic phenotype and geno-
type, and cannot be diagnosed with confidence on
morphological grounds alone and are often labelled
as undifferentiated sarcoma. It is likely that several
of these will be reclassified based on genetic changes
associated in recently described cases. Next to the
TET/ETS fusions cases of ‘Ewing-like sarcomas’ have
been identified with fusions between EWSR1 and
other non TET-proteins such as NFATc2, ZSG,
POU5F1 and others.
3,4
Moreover cases have been
identified without similarities to EWSR1-based
fusions. Such an example is a recently described
recurrent translocation t(4;19)(q35;q13) in a propor-
tion of undifferentiated sarcomas.
5–10
The transloca-
tion results in the fusion of the CIC gene to the
C-terminal part of the DUX4 gene located at 19q13
or 4q35 regions, respectively.
10
Case history
A 62-year-old woman detected a small nodule in her
right inguinal region in 2010, which showed rapid
progression within 3 months. FNA was performed,
followed by the resection of a 110 9 85 9 80-mm
necrotic tumour. No association with the peripheral
nerves was seen. No lymph node or distant metasta-
ses were detected. The patient received radiotherapy
and chemotherapy. Another resection was performed
4 months after the first because of local recurrence.
Significant progression was seen in 3 months with
the appearance of multiple pulmonary metastases
and an additional mass in the left thigh. Radiother-
Correspondence:
B. Kajt ar, Department of Pathology, University of P ecs, Pf.:
99, P ecs 7602, Hungary.
Tel.: +36-72-526-282; Fax: +36-72-526-281; E-mail: bela.
kajtar@kk.pte.hu
DOI:10.1111/cyt.12079
1
© 2013 John Wiley & Sons Ltd
Cytopathology 2013